Autophagy Disruptions Associated With Altered Optineurin Expression in Extranigral Regions in a Rotenone Model of Parkinson's Disease

被引:9
|
作者
Wise, John P., Jr. [1 ,2 ]
Price, Charles G. [1 ]
Amaro, Joseph A. [1 ,3 ]
Cannon, Jason R. [1 ,2 ]
机构
[1] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA
[2] Purdue Univ, Purdue Inst Integrat Neurosci, W Lafayette, IN 47907 USA
[3] Univ Illinois, Sch Publ Hlth, Chicago, IL USA
来源
FRONTIERS IN NEUROSCIENCE | 2018年 / 12卷
基金
美国国家卫生研究院;
关键词
Parkinson's disease; rotenone; autophagy; optineurin; LC3; GENE-ENVIRONMENT INTERACTIONS; MITOCHONDRIAL-DNA DAMAGE; LEWY BODY DISEASES; ALPHA-SYNUCLEIN; DOPAMINERGIC-NEURONS; NIGRAL NEURONS; DIAGNOSTIC-CRITERIA; OXIDATIVE STRESS; PATHOLOGY; LOCALIZATION;
D O I
10.3389/fnins.2018.00289
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The motor features of Parkinson's disease (PD) primarily result from a lesion to the nigrostriatal dopamine system. Numerous non-motor symptoms occur in PD, many of which are postulated to stem from pathology outside of the nigrostriatal dopamine system. Perturbations to protein trafficking, disruption of mitochondrial integrity, and impaired autophagy have repeatedly been implicated in dopaminergic neuron cell death. Previously, we demonstrated that multiple markers of autophagy are disrupted in a rotenone model of PD, with alterations occurring prior to an overt lesion to the nigrostriatal dopamine system. Whether these events occur in extra-nigral nuclei in PD and when relative to a lesion in the nigrostriatal dopamine system are generally unknown. The primary goal of these studies was to determine whether autophagy disruptions, in non-dopaminergic neuronal populations occur in an environmental model of PD utilizing a mitochondria' toxin. Here, we utilized the rat rotenone PD model, with sampling time-points before and after an overt lesion to the nigrostriatal dopamine system. In analyzing autophagy changes, we focused on optineurin (OPTN) and the autophagy marker, LC3. OPTN is an autophagy cargo adapter protein genetically linked to amyotrophic lateral sclerosis and glaucoma. In the present study, we observed OPTN enrichment in all PD-relevant brain regions examined. Further, alterations in OPTN and LC3 expression and colocalized puncta suggest specific impairments to autophagy that will inform future mechanistic studies. Thus, our data suggest that autophagy disruptions may be critical to PD pathogenesis in non-dopaminergic neurons and the onset of non-motor symptoms.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] NEUROPROTECTION BY VALPROIC ACID IN AN INTRASTRIATAL ROTENONE MODEL OF PARKINSON′S DISEASE
    Carriere, C. H.
    Kang, N. H.
    Niles, L. P.
    NEUROSCIENCE, 2014, 267 : 114 - 121
  • [22] Animal model of Parkinson's disease induced by chronic administration of rotenone
    Kobayashi, Yuka
    Inden, Masatoshi
    Kitamura, Yoshihisa
    Taniguchi, Takashi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2005, 125 : 124 - 126
  • [23] Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease
    Ulusoy, Gokhan K.
    Celik, Turgay
    Kayir, Hakan
    Gursoy, Murat
    Isik, Ahmet T.
    Uzbay, Tayfun I.
    BRAIN RESEARCH BULLETIN, 2011, 85 (06) : 380 - 384
  • [24] Propionic Acid and Fasudil as Treatment against Rotenone Toxicity in an In Vitro Model of Parkinson's Disease
    Ostendorf, Friederike
    Metzdorf, Judith
    Gold, Ralf
    Haghikia, Aiden
    Toenges, Lars
    MOLECULES, 2020, 25 (11):
  • [25] Recuperative effect of estrogen on rotenone-induced experimental model of Parkinson's disease in rats
    Makav, Mustafa
    Eroglu, Huseyin Avni
    ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2021, 28 (17) : 21266 - 21275
  • [26] Increased SUMO-1 expression in the unilateral rotenone-lesioned mouse model of Parkinson's disease
    Weetman, J.
    Wong, M. B.
    Sharry, S.
    Rcom-H'cheo-Gauthier, A.
    Gai, W. P.
    Meedeniya, A.
    Pountney, D. L.
    NEUROSCIENCE LETTERS, 2013, 544 : 119 - 124
  • [27] Evaluation of mice treatment with aluminium chloride in rotenone model of Parkinson's disease
    El-Shamarka, Marwa El-Sayed
    Abdel-Salam, M. E.
    Omara, Enayat A.
    EGYPTIAN JOURNAL OF CHEMISTRY, 2024, 67 (09): : 159 - 171
  • [28] Effect of methylglyoxal on Parkinson's disease pathophysiology in the rotenone model
    Culpan, Yekta
    Ozden, Lara
    Gozderesi, Yakup
    Kocak, Beril
    Baltaci, Zeynep Hazal
    Denizli, Ayberk
    Karademir Yilmaz, Betul
    Gulhan, Rezzan
    MARMARA MEDICAL JOURNAL, 2024, 37 (02): : 166 - 177
  • [29] Fenofibrate promotes neuroprotection in a model of rotenone-induced Parkinson's disease
    Barbiero, Janaina K.
    Ramos, Daniele C.
    Boschen, Suelen
    Bassani, Taysa
    Da Cunha, Claudio
    Vital, Maria A. B. F.
    BEHAVIOURAL PHARMACOLOGY, 2022, 33 (08): : 513 - 526
  • [30] Neuroprotective Effect of Curcumin on the Rat Model of Parkinson's Disease Induced by Rotenone via Modulating Tyrosine Hydroxylase and Dopa Decarboxylase Expression Levels
    Essawy, Amina E.
    Matta, Cecil A.
    Nabil, Basant
    Abd Elkader, Heba-Tallah Abd Elrahim
    Alhasani, Reem Hasaballah
    Soffar, Ahmed A.
    NEUROCHEMICAL JOURNAL, 2023, 17 (03) : 457 - 466